Back to top


  /    /  LACOG 0217 – IRONMAN

Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer

Type of Study: Epidemiological

Sponsor / Support: LACOG, Movember

Primary Objectives: Describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer and overall survival and identify clinical and molecular disease subtypes that predict response to individual treatments, combinations or sequences.

Sample Size: 5.000 patients

Principal Investigator: Andre Fay

Countries LATAM: Brazil